Accession Number ADA582218
Title Military Vaccines in Today's Environment.
Publication Date Aug 2012
Media Count 4p
Personal Author A. M. Friedlander C. S. Schmaljohn L. A. Smith
Abstract The U.S. military has a long and highly distinguished record of developing effective vaccines against pathogens that threaten the armed forces. Many of these vaccines also have been of significant benefit to civilian populations around the world. The current requirements for force protection include vaccines against endemic disease threats as well as against biological warfare or bioterrorism agents, to include novel or genetically engineered threats. The cost of vaccine development and the modern regulatory requirements for licensing vaccines have strained the ability of the program to maintain this broad mission. Without innovative vaccine technologies, streamlined regulatory strategies, and coordinating efforts for use in civilian populations where appropriate, the military vaccine development program is in jeopardy.
Keywords Alternative licensing strategies
Animal models
Biological warfare
Bioterrorism
Force protection
High costs
History
Infectious diseases
Investigational new drug vaccines
Licensing costs
Military forces(United states)
Military medicine
Military personnel
Military research
Military vaccine development program
Pathogenic microorganisms
Plasmid dna vaccines
Protection
Regulations
Reprints
Special immunizations program
Vaccines

 
Source Agency Non Paid ADAS
NTIS Subject Category 57E - Clinical Medicine
57Q - Pharmacology & Pharmacological Chemistry
74 - Military Sciences
74D - Chemical, Biological, & Radiological Warfare
Corporate Author Army Medical Research Inst. of Infectious Diseases, Fort Detrick, MD.
Document Type Journal article
Title Note Journal article.
NTIS Issue Number 1326
Contract Number N/A

Science and Technology Highlights

See a sampling of the latest scientific, technical and engineering information from NTIS in the NTIS Technical Reports Newsletter

Acrobat Reader Mobile    Acrobat Reader